Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1310 of 5804
-
New eczema cream shows promise in phase 3 trial
Symptom relief CompletedThis study will assess the safety and efficacy of Roflumilast cream versus vehicle applied once a day for 4 weeks by subjects with atopic dermatitis.
Phase: PHASE3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 12:51 UTC
-
New daily pill hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis is a multi-center, open-label study to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity of REC-1245 administered orally on a once daily (QD) schedule in participants with unresectable, locally advanced, or metastati…
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo aims to shrink mouth cancer before surgery
Disease control Recruiting nowTo learn if giving cemiplimab and cetuximab before salvage surgery can help to control recurrent oral cavity squamous cell carcinoma.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Lung cancer treatment could get easier: shot may replace IV infusion
Disease control OngoingResearchers are looking for new ways to treat non-small cell lung cancer (NSCLC) that is metastatic, which means cancer has spread to other parts of the body. Some people with metastatic NSCLC are treated with pembrolizumab, an immunotherapy treatment that is given into a vein a…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New liver stent aims to tame deadly cirrhosis complications
Disease control Recruiting nowThis Study is a prospective, multi-center, single-arm objective perform an criteria (OPC) study. A 12 months follow-up study on the patients who intend to receive the treatment of cirrhosis and complications of portal hypertension with the TIPS Stent Graft will be conducted. The …
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a drug for eczema soothe the agony of Post-Burn itch?
Symptom relief Recruiting nowThe goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.
Phase: PHASE2 • Sponsor: Akron Children's Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 19:19 UTC
-
Herbal hope: can ancient formula mend Sepsis-Damaged hearts?
Disease control Recruiting nowThe goal of this clinical trial is to learn if Chinese medicine - Yiqilishui formula works to treat sepsis-induced myocardial dysfunction (SIMD). It will also learn about the safety of Yiqilishui formula. The main questions it aims to answer are: * Compared with conventional wes…
Phase: PHASE2 • Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Should you get your COVID and flu shots together? new study aims to find out for immunocompromised patients
Knowledge-focused Recruiting nowThe goal of this pragmatic embedded open-label, 2 x 2 factorial phase II randomized controlled trial is to evaluate strategies to improve COVID-19 booster and influenza vaccine immunogenicity in people living with immunocompromising conditions (PLIC). The main questions it aims …
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Could a pill replace needles for anemia in dialysis?
Disease control OngoingThis trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment of anemia in in-center hemodialysis patients with End Stage Kidney Disease (ESKD…
Phase: PHASE3 • Sponsor: USRC Kidney Research • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New oral paclitaxel trial offers hope for Hard-to-Treat GIST
Disease control Recruiting nowThe purpose of this study is to evaluate safety and efficacy of Liporaxel for patients with GIST who failed on prior standard treatments, including imatinib, sunitinib, and regorafenib, and with low P-glycoprotein expression.
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Your voice may reveal hidden depression: new app screens students by speech
Diagnosis CompletedMajor depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the…
Sponsor: Accexible • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
Can an online program help people cut back on alcohol?
Disease control OngoingGuided internet-based treatment for individuals with harmful alcohol use, eBehandling Alkohol (eBA), will be implemented as an experimental treatment option in five hospitals autumn 2024. Concurrently, a research project related to the effects of eBA will be conducted. Results fr…
Phase: NA • Sponsor: Sykehuset i Vestfold HF • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Kidney shield? diabetes drug shows promise for teens
Disease control CompletedEffect of Sodium-Glucose Cotransporter (SGLT) 2 Inhibitors on Diabetic Nephropathy Progression in Adolescents with Type 1 Diabetes Mellitus
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New dialyser aims to cut blood thinner risks for kidney patients
Disease control CompletedThe aim of the study is to evaluate the efficacy of the SOLACEA-H dialyser, particularly in patients at high risk of haemorrhage, during post-dilution haemodiafiltration sessions with complete or partial heparin sparing. It will be compared with another dialyser (HYDROLINK-NVU)
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smartphone app could help stroke survivors speak clearly again
Disease control CompletedThe goal of this interventional study is to evaluate the efficacy and safety of a digital therapeutic (DTx) application, \'repeech\', for the treatment of post-stroke dysarthria. The study aims to assess improvement in speech intelligibility in individuals affected by pos…
Phase: NA • Sponsor: HAII corp.ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New HIV pill combo could simplify treatment for kids
Disease control OngoingThe goal of this clinical study is to learn about the safety and tolerability of bictegravir/lenacapavir (BIC/LEN) and to learn how the study drug interacts with the body in virologically suppressed (VS) children and adolescents with human immunodeficiency virus type 1 (HIV-1) on…
Phase: PHASE2, PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a common cholesterol pill fight cervical cancer? new trial investigates
Disease control Recruiting nowNormally, p53 helps prevent tumors from forming in the body. Early studies have shown that Fenofibrate, a cholesterol-lowering drug, can restore normal function to p53 and can change the metabolism of HPV-positive tumors in a way that stops the growth of tumors. The purpose of th…
Phase: PHASE1 • Sponsor: Lindsay Ferguson, MD • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New weight loss drug shows promise in Long-Term Follow-Up study
Disease control CompletedThe Objective of this trial is to evaluate the long-term safety, tolerability, weight loss efficacy and metabolic benefits of HRS-7535 tablets inobesity.
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Radioactive probes could light up pancreatic tumors for smarter treatment
Diagnosis Recruiting nowPancreatic cancer remains one of the most aggressive cancer types. Target-specific targeted therapy is an attractive therapeutic alternative for the treatment of patients with a wide range of cancers, including pancreatic cancer. Companion diagnostic technique is critical for the…
Phase: NA • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New app-based program aims to boost brain development in premature babies
Disease control Recruiting nowResearch problem and specific questions More than 1000 very preterm infants (\< 32 weeks) are born every year in Sweden. They are at high risk of neurodevelopmental disabilities and mental illness throughout the lifespan. The overall purpose is to develop and evaluate…
Phase: NA • Sponsor: Umeå University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC